Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nanotech Biomarkers For Renal Cancer Intervention: Clinical Validation & Utility

NCT02923284 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02923284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02923284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nanotech Biomarkers For Renal Cancer Intervention: Clinical Validation & Utility
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Completed
Start date
August 31, 2016
Completion date
January 2, 2020
Enrollment
407 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell cancer, renal cell carcinoma